- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-11-0029280

D Cross Pharmaceuticals Private Limited
About D Cross Pharmaceuticals Private Limited
Data last updated:
D Cross Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 02 March 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24303DL2022PTC394523.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Girraj Giri and Somdutt Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hardyal Singh C 74 Kh No 74/3/2 Nihal Vihar Nangloi, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.86 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net loss of ₹38,531 (net margin -3%) and EBITDA of -₹23,359 (EBITDA margin -1.8%).
D Cross Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0029280). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of D Cross Pharmaceuticals
Contact details
D Cross Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressHardyal Singh C 74 Kh No 74/3/2 Nihal Vihar Nangloi, Delhi, India – 110041
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of D Cross Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of D Cross Pharmaceuticals Private Limited, buy the company report.
Financials of D Cross Pharmaceuticals Private Limited
FY 2025 filings availableD Cross Pharmaceuticals Private Limited reported revenue of ₹12.86 Lakh (up 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 34% in the latest year. EBITDA fell 314% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹23,359 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹38,531 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.8% | |||
| Net Profit Margin | -3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of D Cross Pharmaceuticals Private Limited, buy the company report.
Board of directors of D Cross Pharmaceuticals Private Limited
D Cross Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girraj Giri | Director | 02 Mar 2022 | 4 Years 8 Months | Current |
| Somdutt Sharma | Director | 02 Mar 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving D Cross Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for D Cross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for D Cross Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
D Cross Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Girraj Giri was appointed as Director on 02 Mar 2022.
Frequently asked questions
D Cross Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 02 March 2022 (4+ years old) and is registered under CIN U24303DL2022PTC394523.
D Cross Pharmaceuticals has 2 current directors:
- Girraj Giri - Director
- Somdutt Sharma - Director
The latest financial statements of D Cross Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of D Cross Pharmaceuticals is U24303DL2022PTC394523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
D Cross Pharmaceuticals was incorporated on 02 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Girraj Giri was appointed as Director on 02 Mar 2022. Somdutt Sharma was appointed as Director on 02 Mar 2022.
Yes, D Cross Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0029280).
The registered office of D Cross Pharmaceuticals is at Hardyal Singh C 74 Kh No 7432 Nihal Vihar Nangloi, Delhi, India – 110041.
D Cross Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
The compliance status of D Cross Pharmaceuticals is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.

